NCT00488670

Brief Summary

To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2010

Shorter than P25 for phase_3

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 20, 2007

Completed
3.5 years until next milestone

Study Start

First participant enrolled

December 1, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

June 6, 2011

Status Verified

June 1, 2011

Enrollment Period

6 months

First QC Date

June 18, 2007

Last Update Submit

June 2, 2011

Conditions

Keywords

Alzheimer's diseaseelderlyopen-labelescitalopram

Outcome Measures

Primary Outcomes (1)

  • Change in Cornell Scale for Depression in Dementia (CSDD) from baseline.

Secondary Outcomes (1)

  • Montgomery-Åsberg Depression Rating Scale; Neuropsychiatric Inventory; Alzheimer's Disease Cooperative Study

Interventions

See Detailed Description.

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 50 years
  • Male \& female
  • Alzheimer's disease
  • Depressive episode

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mt. St. Joseph's Hospital

Vancouver, British Columbia, Canada

Location

Vancouver General Hospital

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Depressive DisorderAlzheimer Disease

Interventions

Escitalopram

Condition Hierarchy (Ancestors)

Mood DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive Disorders

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic ChemicalsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Kiran Rabheru, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 18, 2007

First Posted

June 20, 2007

Study Start

December 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

June 6, 2011

Record last verified: 2011-06

Locations